Beneficial actions of S-nitroso-N-acetylpenicillamine, a nitric oxide donor, in murine traumatic shock
- PMID: 7743323
- DOI: 10.1097/00024382-199401000-00004
Beneficial actions of S-nitroso-N-acetylpenicillamine, a nitric oxide donor, in murine traumatic shock
Abstract
We studied the effects of the nitric oxide donor, S-nitroso-N-acetylpenicillamine (SNAP), in rat traumatic shock characterized by hypotension, increases in plasma free amino-nitrogen (5.3 +/- 0.5 U/ml vs. 2.5 +/- 0.3 U/ml controls) and intestinal myeloperoxidase activities (2.7 +/- 1.0 U/100 mg vs. 0.2 +/- 0.1 U/100 mg controls), and a survival time of 143 +/- 20 min. Moreover, superior mesenteric artery rings isolated from rats in traumatic shock relaxed to the endothelium-dependent vasodilator acetylcholine only 21 +/- 6% of U-46619 induced contraction. Administration of 100 micrograms/kg SNAP 10 min post-trauma followed by 10 micrograms/kg/h infusion prolonged survival time to 273 +/- 18 min (p < .05), attenuated the increases in plasma free amino-nitrogen (3.1 +/- 0.4 U/ml, p < .05) and tissue myeloperoxidase activities (0.6 +/- 0.3 U/100 mg, p < .05). Moreover, SNAP significantly preserved superior mesenteric artery endothelial function; the vasorelaxation to acetylcholine was 54 +/- 4% (p < .01). Protective effects were not seen in traumatic shock rats treated with the non-NO-donating parent compound N-acetylpenicillamine. These results indicate that SNAP affords significant protection in murine traumatic shock which may be achieved through maintenance of systemic blood pressure, preservation of vascular endothelial integrity, and inhibition of neutrophil-endothelial interaction and the resultant reduced microvascular leakiness.
Similar articles
-
Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock.Methods Find Exp Clin Pharmacol. 1992 Dec;14(10):789-97. Methods Find Exp Clin Pharmacol. 1992. PMID: 1338473
-
Attenuation by nitrosothiol NO donors of acute intestinal microvascular dysfunction in the rat.Br J Pharmacol. 1995 Jun;115(3):498-502. doi: 10.1111/j.1476-5381.1995.tb16361.x. Br J Pharmacol. 1995. PMID: 7582463 Free PMC article.
-
Beneficial actions of CP-0127, a novel bradykinin receptor antagonist, in murine traumatic shock.Am J Physiol. 1994 Mar;266(3 Pt 2):H867-73. doi: 10.1152/ajpheart.1994.266.3.H867. Am J Physiol. 1994. PMID: 8160833
-
Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug.Br J Pharmacol. 1997 Dec;122(8):1617-24. doi: 10.1038/sj.bjp.0701557. Br J Pharmacol. 1997. PMID: 9422806 Free PMC article.
-
Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.Br J Pharmacol. 1996 Sep;119(1):23-8. doi: 10.1111/j.1476-5381.1996.tb15672.x. Br J Pharmacol. 1996. PMID: 8872352 Free PMC article.
Cited by
-
Fabrication and Optimization of Poly(ε-caprolactone) Microspheres Loaded with S-Nitroso-N-Acetylpenicillamine for Nitric Oxide Delivery.Biomedicines. 2024 Jun 19;12(6):1363. doi: 10.3390/biomedicines12061363. Biomedicines. 2024. PMID: 38927571 Free PMC article.
-
Nitric oxide. Novel biology with clinical relevance.Ann Surg. 1995 Apr;221(4):339-49. doi: 10.1097/00000658-199504000-00003. Ann Surg. 1995. PMID: 7537035 Free PMC article. Review.
-
Vascular endothelial growth factor attenuates trauma-induced injury in rats.Br J Pharmacol. 2000 Jan;129(1):71-6. doi: 10.1038/sj.bjp.0703010. Br J Pharmacol. 2000. PMID: 10694204 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials